199 related articles for article (PubMed ID: 19184002)
1. Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity.
Abdel-Motal UM; Wigglesworth K; Galili U
Cancer Immunol Immunother; 2009 Oct; 58(10):1545-56. PubMed ID: 19184002
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines.
Galili U; Wigglesworth K; Abdel-Motal UM
J Immunol; 2007 Apr; 178(7):4676-87. PubMed ID: 17372027
[TBL] [Abstract][Full Text] [Related]
3. Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction.
Galili U
Clin Dev Immunol; 2011; 2011():134020. PubMed ID: 22162709
[TBL] [Abstract][Full Text] [Related]
4. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
5. In Situ Conversion of Melanoma Lesions into Autologous Vaccine by Intratumoral Injections of α-gal Glycolipids.
Galili U; Albertini MR; Sondel PM; Wigglesworth K; Sullivan M; Whalen GF
Cancers (Basel); 2010; 2(2):773-93. PubMed ID: 23087817
[TBL] [Abstract][Full Text] [Related]
6. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy by intratumoral injection of α-gal glycolipids.
Whalen GF; Sullivan M; Piperdi B; Wasseff W; Galili U
Anticancer Res; 2012 Sep; 32(9):3861-8. PubMed ID: 22993330
[TBL] [Abstract][Full Text] [Related]
8. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
9. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
Galili U
Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
[TBL] [Abstract][Full Text] [Related]
10. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
[TBL] [Abstract][Full Text] [Related]
11. Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Taniyama K; Kamiike W; Mori M; Doki Y
Cancer Sci; 2013 Mar; 104(3):282-90. PubMed ID: 23240661
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells.
Abdel-Motal UM; Guay HM; Wigglesworth K; Welsh RM; Galili U
J Virol; 2007 Sep; 81(17):9131-41. PubMed ID: 17609270
[TBL] [Abstract][Full Text] [Related]
13. Phase I study to evaluate toxicity and feasibility of intratumoral injection of α-gal glycolipids in patients with advanced melanoma.
Albertini MR; Ranheim EA; Zuleger CL; Sondel PM; Hank JA; Bridges A; Newton MA; McFarland T; Collins J; Clements E; Henry MB; Neuman HB; Weber S; Whalen G; Galili U
Cancer Immunol Immunother; 2016 Aug; 65(8):897-907. PubMed ID: 27207605
[TBL] [Abstract][Full Text] [Related]
14. Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.
Wigglesworth KM; Racki WJ; Mishra R; Szomolanyi-Tsuda E; Greiner DL; Galili U
J Immunol; 2011 Apr; 186(7):4422-32. PubMed ID: 21357545
[TBL] [Abstract][Full Text] [Related]
15. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.
Tanemura M; Miyoshi E; Nagano H; Eguchi H; Matsunami K; Taniyama K; Hatanaka N; Akamatsu H; Mori M; Doki Y
World J Gastroenterol; 2015 Oct; 21(40):11396-410. PubMed ID: 26523105
[TBL] [Abstract][Full Text] [Related]
17. Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction.
Galili U; Wigglesworth K; Abdel-Motal UM
Burns; 2010 Mar; 36(2):239-51. PubMed ID: 19501971
[TBL] [Abstract][Full Text] [Related]
18. In situ conversion of tumors into autologous tumor-associated antigen vaccines by intratumoral injection of α-gal glycolipids.
Galili U
Oncoimmunology; 2013 Jan; 2(1):e22449. PubMed ID: 23483105
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated antigen/IL-21-transduced dendritic cell vaccines enhance immunity and inhibit immunosuppressive cells in metastatic melanoma.
Aravindaram K; Wang PH; Yin SY; Yang NS
Gene Ther; 2014 May; 21(5):457-67. PubMed ID: 24572790
[TBL] [Abstract][Full Text] [Related]
20. Expression of alpha-gal epitopes on ovarian carcinoma membranes to be used as a novel autologous tumor vaccine.
Galili U; Chen ZC; DeGeest K
Gynecol Oncol; 2003 Jul; 90(1):100-8. PubMed ID: 12821349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]